Ch. M. Zwaan

559 total citations
8 papers, 365 citations indexed

About

Ch. M. Zwaan is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Ch. M. Zwaan has authored 8 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Ch. M. Zwaan's work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Ch. M. Zwaan is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Ch. M. Zwaan collaborates with scholars based in Netherlands, Germany and Belgium. Ch. M. Zwaan's co-authors include Gertjan J.L. Kaspers, Ursula Creutzig, Dirk Reinhardt, Bianca F. Goemans, K. Hählen, A. H. Loonen, Michael C. Heinrich, Amy Harlow, M Zimmermann and Soheil Meshinchi and has published in prestigious journals such as British Journal of Haematology, Leukemia and Pediatric Research.

In The Last Decade

Ch. M. Zwaan

8 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ch. M. Zwaan Netherlands 6 301 131 97 82 42 8 365
Patrizia Scaravaglio Italy 8 199 0.7× 157 1.2× 86 0.9× 78 1.0× 34 0.8× 18 346
Mirjam Klaus Greece 6 343 1.1× 165 1.3× 128 1.3× 111 1.4× 37 0.9× 10 413
Marilena Caresana Italy 10 276 0.9× 89 0.7× 131 1.4× 53 0.6× 23 0.5× 20 314
Barbara Rocca Italy 9 274 0.9× 86 0.7× 127 1.3× 52 0.6× 23 0.5× 21 310
Magda Šišková Czechia 10 344 1.1× 123 0.9× 131 1.4× 32 0.4× 61 1.5× 22 395
Maria Gracia Gonzalez Spain 7 202 0.7× 182 1.4× 63 0.6× 70 0.9× 68 1.6× 8 380
Harmony Leroy France 5 340 1.1× 155 1.2× 134 1.4× 91 1.1× 26 0.6× 9 382
Erica Simeone Italy 12 284 0.9× 135 1.0× 60 0.6× 124 1.5× 70 1.7× 22 391
Federica Cattina Italy 9 187 0.6× 136 1.0× 80 0.8× 51 0.6× 19 0.5× 35 282

Countries citing papers authored by Ch. M. Zwaan

Since Specialization
Citations

This map shows the geographic impact of Ch. M. Zwaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ch. M. Zwaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ch. M. Zwaan more than expected).

Fields of papers citing papers by Ch. M. Zwaan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ch. M. Zwaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ch. M. Zwaan. The network helps show where Ch. M. Zwaan may publish in the future.

Co-authorship network of co-authors of Ch. M. Zwaan

This figure shows the co-authorship network connecting the top 25 collaborators of Ch. M. Zwaan. A scholar is included among the top collaborators of Ch. M. Zwaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ch. M. Zwaan. Ch. M. Zwaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Klein, Kim, Eric G. Haarman, Válerie de Haas, et al.. (2016). Glucocorticoid-Induced Proliferation in Untreated Pediatric Acute Myeloid Leukemic Blasts. Pediatric Blood & Cancer. 63(8). 1457–1460. 12 indexed citations
2.
Cloos, Jacqueline, Bianca F. Goemans, Corine J. Hess, et al.. (2006). Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Leukemia. 20(7). 1217–1220. 140 indexed citations
3.
Goemans, Bianca F., Ch. M. Zwaan, M Zimmermann, et al.. (2005). Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia. 19(9). 1536–1542. 174 indexed citations
4.
Zwaan, Ch. M. & Gertjan J.L. Kaspers. (2004). Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia. British Journal of Haematology. 127(3). 264–279. 18 indexed citations
5.
Pieters, Rob, Gertjan J.L. Kaspers, Monique L. den Boer, et al.. (1999). Resistance Testing and Mechanisms of Resistance in Childhood Leukemia. Advances in experimental medicine and biology. 457. 391–395. 2 indexed citations
6.
Rots, Marianne G., Ch. M. Zwaan, R. Pieters, et al.. (1999). Continuous Exposure to Methotrexate (MTX) Overcomes Resistance in Childhood Acute Myeloid Leukemia (AML) in Vitro. Pediatric Research. 45. 775–775. 1 indexed citations
7.
Kaspers, Gertjan J.L., Ch. M. Zwaan, R. Pieters, & A. Veerman. (1999). Cellular drug resistance in childhood acute myeloid leukemia. A mini-review with emphasis on cell culture assays.. PubMed. 457. 415–21. 7 indexed citations
8.
Schuil, J., et al.. (1998). Retinopathy following measles, mumps, and rubella vaccination in an immuno-incompetent girl. International Ophthalmology. 22(6). 345–347. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026